Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02593227
Recruitment Status : Active, not recruiting
First Posted : November 2, 2015
Last Update Posted : January 28, 2019
Sponsor:
Information provided by (Responsible Party):
Marker Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021